Connect with us

Press Release

CyberGlobal Announces Significant Expansion Across the United States, Establishing Key Regional Headquarters

Published

4 months ago

on

United States, 28th Mar 2025 – CyberGlobal, a leading global cybersecurity firm, today announced a major expansion across the United States with the establishment of multiple key regional headquarters. This strategic initiative underscores the company’s strong commitment to addressing the escalating cybersecurity challenges faced by organizations nationwide and delivering localized expertise backed by global resources.

CyberGlobal is establishing a significant presence in several strategic locations, including Atlanta (Georgia Headquarters), Boston (Massachusetts Headquarters), Caribbean (Caribbean Headquarters), Dallas (Texas Headquarters), North Carolina (North Carolina Headquarters), Philadelphia (Pennsylvania Headquarters), and Tampa.

This multi-location strategy will enable CyberGlobal to provide tailored cybersecurity services and build strong, lasting partnerships with businesses across various regions of the United States. Each headquarters will serve as a hub for local expertise, supported by CyberGlobal’s global threat intelligence and extensive service portfolio, including penetration testing, managed security services, and incident response.

“The United States is a critical battleground in the ongoing fight against cyber threats,” said a representative from CyberGlobal’s global leadership team. “We are committed to providing comprehensive and accessible cybersecurity solutions to organizations throughout the US. By establishing these key regional headquarters, we are ensuring that our clients receive the personalized attention and local understanding they need, backed by the strength and expertise of our global team.”

“This expansion marks an exciting new chapter for CyberGlobal in the United States,” said Ken Boyce, a key leader in CyberGlobal’s US strategy. “Our distributed model allows us to be closer to our clients, understand their specific regional challenges, and deliver solutions that are both globally informed and locally relevant. We are building strong teams in each of these locations, comprised of experienced cybersecurity professionals dedicated to protecting US businesses.”

CyberGlobal’s strategic expansion across the United States demonstrates its long-term vision for the North American market and its unwavering commitment to providing accessible, expert-led cybersecurity services to organizations nationwide.

About CyberGlobal:

CyberGlobal is a leading global cybersecurity firm with a strong reputation for delivering cutting-edge solutions and expert services to clients worldwide.

Media Contact

Organization: CyberGlobal USA LLC

Contact Person: Ken Boyce, Managing Director

Website: https://cybergl.com

Email: Send Email

Contact Number: +19413265755

Address:30 North Gould Street, Suite R Sheridan, Wyoming 82801

Country:United States

Release id:25837

View source version on King Newswire:
CyberGlobal Announces Significant Expansion Across the United States, Establishing Key Regional Headquarters

It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it.

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Related Topics:
Continue Reading

Press Release

Global Natural History Day 2025 Global Finals Kicks Off at Shanghai University

Published

15 minutes ago

on

July 21, 2025

By

On the afternoon of July 18, the Global Natural History Day® 2025 Global Finals, co-organized by the National Museum of Natural History, the Global Health and Education Foundation, and Shanghai University, officially commenced at the Baoshan Campus Gymnasium of Shanghai University. The event aims to strengthen cultural exchange among youth and foster the development of natural sciences. 

Attending the opening ceremony were Xue Li, Chairman of the China Association of Natural Science Museums (CANSM); Wan Shilin, Party Secretary of the National Museum of Natural History; Stephen P. Beinke, President of Behring Global Educational Foundation; Shen Anqi, Vice President of Behring Global Educational Foundation; Liu Changsheng, President of Shanghai University and Academician of the Chinese Academy of Sciences; and Duan Yong, Deputy Party Secretary of Shanghai University. 

A total of 640 teams from 14 regions across China and three specially invited areas will participate in a series of activities over five days, competing in five categories: science exhibitions, science performances, science topic presentation, science-themed artwork, and storytelling, in a grand showdown of natural science exploration. 

During the ceremony, Stephen P. Beinke reflected on the development of Global Natural History Day since its launch in 2012. On behalf of the Global Health and Education Foundation, he expressed gratitude to partners for their contributions to the sustainable development of natural science museums and encouraged participants to fully experience the event’s unique appeal. 

Xue Li extended congratulations on the opening of the 2025 Finals, noting that the program aligns closely with museum-based education philosophies by extending resources into broader social spaces and inspiring young minds’ passion for science.  

Wan Shilin emphasized that the true value of Global Natural History Day lies in nurturing scientific curiosity among youth and fostering a generation that instinctively values nature conservation. 

Liu Changsheng highlighted Shanghai University’s commitment to youth innovation in science, underscoring its role in facilitating scientific exploration, research, and public engagement. As an open, inclusive, and innovative institution, the university provides a global platform for young participants to exchange ideas and showcase their talents.

Global Natural History Day® (GNHD®) is a youth natural science extracurricular education activity initiated by Kenneth. E. Behring, the founder of Behring Global Educational Foundation since 2012. It is a nonprofit initiative designed to ignite students’ interest in natural sciences while enhancing their research, analytical, and communication skills. Over its 14-year history, the program has engaged over 100,000 teams, impacting hundreds of thousands of families and millions of students and educators.  

Media Contact

Organization: GNHD®

Contact Person: Ranky Chen

Website: https://gnhday.net/

Email: Send Email

City: Shanghai

Country:China

Release id:31133

The post Global Natural History Day 2025 Global Finals Kicks Off at Shanghai University appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

S.BIOMEDICS Cell Therapy for Parkinson’s Disease Shows Positive Data from Its Phase 1/2a Clinical Trial

Published

15 minutes ago

on

July 21, 2025

By

Seoul, South Korea – 21/07/2025 – (SeaPRwire) – S.BIOMEDICS announced encouraging one-year post-transplant results from Phase 1/2a clinical trial evaluating A9-DPC cell therapy for Parkinson’s disease. The data demonstrate a favorable safety and efficacy profile of A9-DPC in 12 participants at 12 months compared to baseline. Participants were divided equally into a low-dose group (3.15 million cells) and a high-dose group (6.30 million cells).

  • A9-DPC (TED-A9) consists of high-purity ventral midbrain dopaminergic progenitor cells derived from human embryonic stem cells (hESCs) under rigorous GMP conditions.
  • A total of 12 participants received bilateral putamen transplantation with either a low-dose (3.15 million cells; n = 6) or a high-dose (6.30 million cells; n = 6) of A9-DPC, with the last participant receiving treatment in February 2024.
  • At 12 months, the safety profile was favorable, with no tumorigenesis, overgrowth of transplanted cells, ectopic cell migration, or immune-mediated inflammation observed.
  • Clinical improvements were observed, along with evidence of cell survival and engraftment at the 12-month follow-up.
  • Increased dopamine transporter (DAT) signals in putamen, measured by [18F]FP-CIT PET, correlated with the observed improvements of motor function.

The MDS-UPDRS Part III (off) score, a standard scale for assessing motor symptom severity in Parkinson’s disease, showed a mean decrease (improvement) of 12.7 points in the low-dose group and 15.5 points in the high-dose group at 12 months compared to baseline. There were also improvements in MDS-UPDRS Part I, II and IV scores. The MDS-UPDRS Total (off) score showed mean improvements of 29.0 points and 34.7 points in the low- and high-dose groups, respectively.

Clinical improvements were further supported by changes in the Hoehn and Yahr stage, an ordinal scale categorizing disease severity based on motor function. On average, low-dose recipients improved (decreased) from stage 3.7 to 2.7, while high-dose recipients demonstrated a greater improvement from stage 3.8 to 2.2.

A9-DPC also demonstrated favorable outcomes in other assessments, including the Non-Motor Symptoms Scale (NMSS), the Parkinson’s Disease Questionnaire-39 (PDQ-39) and the Schwab and England Activities of Daily Living Scale (SEADL). NMSS score improved by 31.7 points in the low-dose group and by 35.8 points in the high-dose group.

[18F]FP-CIT PET imaging showed an overall increase in putamen DAT signals, with greater increases observed in the high-dose group, providing additional evidence for the underlying mechanism of action. Notably, there was a statistically significant correlation between improvements in MDS-UPDRS Part III (off) scores and increased DAT signal in the posterior dorsal putamen, supporting the hypothesis of synaptic restoration through engrafted cells.

In terms of safety, the safety profile remained favorable. No treatment-emergent adverse events (TEAEs) related to the transplanted cells were reported. Tumorigenesis, cell overgrowth, or ectopic cell migration was not observed. Most of TEAEs were mild to moderate. One participant experienced an asymptomatic mild hemorrhage, but no neurological abnormalities or other serious side effects were observed.

“Our data show a consistent positive trend throughout the study period, demonstrating the favorable safety and efficacy profiles. Importantly, increased DAT signals on PET imaging correlated with the observed behavioral recovery, which is very promising in terms of the mechanism of A9-DPC through neuroimaging.“ said Prof. Dong-Wook Kim of Yonsei University College of Medicine and CTO of S.BIOMEDICS. “We will continue to present additional data through our ongoing study.”

About A9-DPC and Phase 1/2a clinical trial

A9-DPC (also called TED-A9) is an investigational cell therapy designed to replace ventral midbrain-specific dopaminergic neurons lost in patients with Parkinson’s disease. These ventral midbrain-specific dopaminergic cells are derived from hESCs (human embryonic stem cells) by exclusively utilizing small molecules under strict GMP conditions. A9-DPC represents a significant advancement in the field, offering highly purified dopaminergic cells derived from hESCs. Through a stereotactic surgical procedure, these hESC-derived dopaminergic progenitor (precursor) cells are transplanted into three segments of the putamen: the anterior, middle, and posterior sections, with three tracks per each putamen. Bilateral putamina were treated in a single surgical procedure, with cells injected at three points within each track. After transplantation, the progenitor cells are expected to mature into dopaminergic neurons, enhancing neural connectivity and restoring motor function in patients.

The Phase 1/2a clinical trial enrolled 12 participants diagnosed with Parkinson’s disease for more than 5 years who exhibited motor complications such as wearing off, freezing of gait, or dyskinesia. Participants ranged from 50 to 75 years old. An initial low-dose cohort (3.15 million cells) of three patients was first enrolled to assess initial safety including dose-limiting toxicity (DLT) over three months. After confirming safety, an additional three patients received the high dose (6.30 million cells) for similar evaluation. With continued safety confirmation, three more patients were enrolled in each dose group, totaling 12 participants. The final participant received A9-DPC in February 2024.

The primary objective of the Phase 1/2a trial is to evaluate the safety and exploratory efficacy for up to two years post-transplantation, with safety follow-up continuing for an additional three years.

About S.BIOMEDICS

Established in 2005, S.BIOMEDICS Co., Ltd. is a leading innovator in stem cell therapy, specializing in regenerative medicine powered by data-driven biology. Leveraging two core platform technologies, S.BIOMEDICS is currently advancing seven cell therapy programs targeting intractable diseases. Several of its lead candidates are now in clinical development, demonstrating the company’s leadership in advancing cell-based medicine:

  • A9-DPC (TED-A9): Ventral midbrain-specific dopaminergic progenitor cells derived from hESCs for Parkinson’s disease (Phase 1/2a)
  • TED-N: PSA-NCAM-positive neural progenitor cells derived from hESCs for spinal cord injury (Phase 1/2a)
  • FECS-Ad: 3D MSC spheroids for critical limb ischemia (completed Phase 1/2a)

As the foremost authority and trailblazer in Parkinson’s disease treatment in South Korea, S.BIOMEDICS is setting the national standard for cell therapy innovation.

More Information about the Phase 1/2a clinical trial for Parkinson’s disease is available at ClinicalTrials.gov (NCT05887466).

For more information about S.BIOMEDICS, visit https://www.sbiomedics.com/. S.BIOMEDICS is listed on the Korea Exchange and is also the founder and controller of S.THEPHARM (www.sthepharm.com), a corporation specializing in anti-aging products such as HA-Filler.

Media contact

Brand: S.BIOMEDICS

Contact: Sarang Kim

Email: ksr7744@sbiomedics.com

Website: https://www.sbiomedics.com

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

AI Dental Receptionists – How RingDental is Changing the Healthcare Industry with AI-Powered Voice Agents

Published

15 minutes ago

on

July 21, 2025

By

RingDental introduces an AI-powered voice receptionist tailored for dental practices. By reducing missed calls, integrating with popular dental scheduling systems, and handling 24/7 communications, RingDental helps offices increase revenue, streamline operations, and enhance patient experience.

In an era where technology is transforming every aspect of our lives, the healthcare industry is experiencing a profound shift, particularly within dental practices. Leading this change is RingDental, a pioneering service that introduces AI-powered voice receptionists to revolutionize patient interactions and operational efficiency. With a word limit of 1500, this article explores how RingDental is reshaping the healthcare landscape, delivering measurable benefits to dental practices, and enhancing the patient experience through innovative technology.

The Challenge: Missed Calls and Lost Revenue

Dental practices face significant hurdles in managing patient communications effectively. One pressing issue is the high rate of missed calls, which directly impacts revenue and patient satisfaction. Industry data reveals that 38% of calls to dental practices go unanswered, and 87% of new patients sent to voicemail never call back. Considering the average patient value is $514 annually, missing just five calls per week translates to a staggering $13,364 in lost revenue each year. For practices already stretched thin by staffing shortages or managing multiple locations, this represents a critical financial and operational challenge.

RingDental: A Cutting-Edge Solution

RingDental tackles these issues with its AI-powered voice receptionist, a sophisticated tool designed to ensure no call goes unanswered. Leveraging advanced conversational AI, this service offers a suite of features tailored to the needs of dental practices:

  • 24/7 Availability: The AI receptionist answers calls within 5-10 seconds, operating round-the-clock—including after hours, during breaks, and on holidays—ensuring patients always receive prompt attention.
  • Live Booking: Seamlessly integrating with systems like Open Dental, Dentrix, and GHL, it enables real-time appointment scheduling, minimizing errors and eliminating manual entry.
  • Custom Knowledge Base: Tailored to each practice, the AI understands specifics such as providers, services, hours, and insurance details, delivering accurate and personalized responses.
  • Bilingual Support: Offering fluent interactions in English and Spanish, it caters to diverse patient populations, enhancing accessibility.
  • Lead Conversion: It instantly follows up on web leads, Facebook forms, and surveys, converting them into booked appointments.
  • Triage Logic: Smart routing prioritizes urgent calls, ensuring emergencies and new patients are handled promptly.
  • Front Desk Relief: By managing routine inquiries, it frees staff to focus on in-office patient care.

These features collectively address the core problems of missed opportunities and operational inefficiencies, positioning RingDental as a transformative tool in dental practice management.

Transforming the Healthcare Industry

RingDental’s impact extends beyond individual practices, influencing the broader healthcare industry in several key ways:

Operational Efficiency

Automating call handling and scheduling reduces the workload on staff, boosting productivity and cutting costs. Practices can redirect human resources to patient care and strategic tasks, optimizing daily operations.

Enhanced Patient Experience

Patients value the immediate, personalized responses provided by the AI receptionist. This immediacy fosters satisfaction and loyalty, critical drivers of practice growth in a competitive market.

Revenue Growth

By capturing every call and converting leads, RingDental helps practices recover lost revenue. The potential to add over $100,000 annually makes it a powerful growth engine, especially for practices aiming to scale.

Scalability

For multi-location or expanding practices, RingDental offers a flexible solution that adapts to increased call volumes without requiring additional hires, supporting seamless growth.

Data-Driven Decision Making

With advanced analytics, practices gain insights into call patterns and patient behaviors, enabling informed decisions to enhance performance and patient engagement.

Real-World Impact: Voices from the Field

Dental professionals who have adopted RingDental highlight its practical benefits:

  • NoMo Dentures : “Our patients love the immediate response they receive when calling our office. The AI assistant has freed up our front desk staff to provide better in-person experiences.”
  • Dr. Frank Rios, Practice Owner at Baymeadows Park Dental, Jacksonville, FL: “OK, sign us up! We are hooked.”
  • Zamie Mendoza, Office Manager at Dream Dental, Las Vegas, NV: “When I am short-staffed, this is a lifesaver!”

These testimonials underscore how RingDental delivers tangible improvements, from patient satisfaction to operational support.

The Technology Powering RingDental

RingDental’s effectiveness stems from its robust technological foundation:

  • NextHealth Orchestration Layer: Ensures integration with any EHR system via a single API, enhancing compatibility.
  • HIPAA Compliance: Hosted on Azure, it meets stringent security standards to protect patient data.
  • Advanced Analytics: Integration with MCP provides detailed call data insights.
  • Natural Language Processing: Cutting-edge models enable human-like, engaging conversations.
  • Smart Call Routing: Directs calls intelligently based on urgency and type.

This technology ensures reliability, security, and a seamless user experience for both staff and patients.

Overcoming Adoption Concerns

New technology can raise questions, but RingDental addresses common concerns effectively:

  • Patient Acceptance: The AI’s polite, natural interactions are well-received, with negative sentiment calls escalated to staff.
  • Complex Situations: Emergencies are transferred immediately, and insurance queries are handled by collecting details for follow-up.
  • Ease of Integration: A streamlined setup process—enrollment, customization, testing, and training—ensures quick deployment.

Pricing: Value Meets Affordability

RingDental offers tiered plans to suit various practice sizes:

  • Starter Plan: $295/month – Unlimited inbound calls, bilingual support, and more.
  • Live Schedule Plan: $495/month (+$995 setup) – Adds PMS integration and scheduling features.
  • Growth Plan: $895/month (+$1,995 setup) – Includes advanced lead management and automation.

Compared to a full-time receptionist’s annual cost of $55,400, RingDental delivers significant savings, paying for itself in 5-6 weeks.

The Future of Dental Care

As AI continues to evolve, its integration into healthcare will deepen. RingDental is paving the way, offering a glimpse into a future where technology enhances efficiency and patient care. By adopting this solution, dental practices can stay competitive and responsive to modern demands.

 

Media Contact

Organization: RingDental

Contact Person: Dr. Ilya Benjamin

Website: https://ringdental.ai/

Email: Send Email

Contact Number: +17077026703

Address:8685 W. Sahara Ave.

Address 2: Suite 100

City: Las Vegas

State: Nevada

Country:United States

Release id:30825

The post AI Dental Receptionists – How RingDental is Changing the Healthcare Industry with AI-Powered Voice Agents appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST

Like Us
Follow Us
Subscribe Us
Follow Us